- Home
- ALXO vs HUIZ Comparison
ALXO vs HUIZ Comparison
Compare ALXO & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- HUIZ
- Stock Information
- Founded
- ALXO 2015
- HUIZ 2006
- Country
- ALXO United States
- HUIZ China
- Employees
- ALXO N/A
- HUIZ N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- ALXO Health Care
- HUIZ Finance
- Exchange
- ALXO Nasdaq
- HUIZ Nasdaq
- Market Cap
- ALXO 24.0M
- HUIZ 25.3M
- IPO Year
- ALXO 2020
- HUIZ 2020
- Fundamental
- Price
- ALXO $1.17
- HUIZ $2.40
- Analyst Decision
- ALXO Strong Buy
- HUIZ Hold
- Analyst Count
- ALXO 6
- HUIZ 1
- Target Price
- ALXO $3.30
- HUIZ $2.30
- AVG Volume (30 Days)
- ALXO 1.7M
- HUIZ 34.7K
- Earning Date
- ALXO 08-12-2025
- HUIZ 09-24-2025
- Dividend Yield
- ALXO N/A
- HUIZ N/A
- EPS Growth
- ALXO N/A
- HUIZ N/A
- EPS
- ALXO N/A
- HUIZ N/A
- Revenue
- ALXO N/A
- HUIZ $168,454,627.00
- Revenue This Year
- ALXO N/A
- HUIZ $11.94
- Revenue Next Year
- ALXO N/A
- HUIZ $8.15
- P/E Ratio
- ALXO N/A
- HUIZ N/A
- Revenue Growth
- ALXO N/A
- HUIZ 1.28
- 52 Week Low
- ALXO $0.40
- HUIZ $1.50
- 52 Week High
- ALXO $2.59
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- ALXO 75.79
- HUIZ 50.49
- Support Level
- ALXO $0.80
- HUIZ $2.25
- Resistance Level
- ALXO $1.04
- HUIZ $2.68
- Average True Range (ATR)
- ALXO 0.11
- HUIZ 0.30
- MACD
- ALXO 0.05
- HUIZ -0.01
- Stochastic Oscillator
- ALXO 96.85
- HUIZ 43.75
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.